You are here:
PBL News »
FT Technology Licensed to Leading Plant Biotech Company
PBL is delighted to announce that it has entered into a major licence agreement with a leading plant biotechnology company in respect of a new technology for achieving increased seed yield . The licence grants exclusive commercial rights to develop new varieties in a selected list of agricultural crops.
Targeted Drug Delivery System Licensed to Aura Biosciences
PBL is pleased to announce that it has entered into an exclusive, commercial licence with Aura Biosciences Inc, for the exploitation of a particular plant-virus as a vehicle for targeted drug delivery. The technology was developed collaboratively by JIC and Aura scientists, and will now be progressed towards clinical application by Aura.
PBL / JIC Spin-out Procarta Biosystems Receives Major New Investment
Procarta Biosystems Ltd, which is developing a novel class of DNA-based antibiotics capable of tackling drug-resistant infections, announced today a round of equity investment totaling £730,000 with the potential to rise to £1.25 million. Procarta was established in 2007 by founders Dr Michael McArthur and Professor Mervyn Bibb of the John Innes Centre (Norwich, UK) with support of PBL, the technology transfer company of John Innes Centre. The round was led by Morningside Venture Investments Limited and included Procarta’s current investors, Rainbow Seed Fund and Iceni Seedcorn Fund.
PBL Licenses Crop Enhancement Technology to Dow AgroSciences
PBL is pleased to announce it has entered into an exclusive commercial licence agreement with Dow AgroSciences for a technology from the John Innes Centre that enhances the root systems of plants.
Beneforté™ : Broccoli from JIC and IFR Research is Presented to US Fresh Produce Market
The broccoli arises from the work of Professor Richard Mithen and colleagues and is exclusively licensed by PBL to Seminis Vegetable Seeds Inc.
PBL Reaches 500 Technologies
PBL recently coded its 500th technology, in its 15th year of operation. PBL assesses many more technologies than those that are taken forward to the stage of being given an internal code, so we have screened literally thousands of technologies over the years. As well as the 27 different UK Universities and Institutes that have contributed to these 500 technologies, 15 other countries, over four continents, are represented in the technologies managed by PBL. PBL has invested over $6 million just in the costs of patent protection on these technologies. Obviously not all the technologies we take on succeed in reaching commercial uptake, but of the technologies we do progress to file patents on, nearly half of them do go on to generate at least some revenues.
Royal Visit for the Model Gut
Provexis, IFR and PBL Launch Major Collaboration in Heart Health
PBL has signed an agreement with Provexis plc and the Institute of Food Research for a substantial collaborative research and development programme. The partners will develop plant extracts and build on related intellectual property with applications in treatment and reduction of systemic inflammation. PBL nd Provexis have previously filed joint patents in the area, and additional background intellectual property will also be licensed by PBL to Provexis, if the first stage of the programme is successful. Provexis discovers and develops scientifically-proven functional food, medical food and dietary supplement technologies and recently obtained approval from European Commission under Art13(5) for its Fruitflow® antithrombotic technology.
PBL Awarded Major US Patent on Short RNA
Plant Bioscience Limited (PBL) is pleased to announce that the United States Patent Office has allowed claims in its patent application 10/806,253 for detection of short RNA molecules to identify gene silencing in mammals and mammalian cells.
PBL Enters Crop Development Partnerships in China
PBL has entered into agreements with the Institute of Botany of the Chinese Academy of Sciences (IOB-CAS), and with the Jilin Academy of Agricultural Sciences (JAAS). IOB-CAS has established a new Centre for Bioenergy which will develop sweet sorghum as a strategic bioenergy crop for China, while JAAS is the national centre for maize transformation and has a long track record of breeding and delivering maize and sorghum varieties for the Chinese market. Under the agreements, IOB-CAS and JAAS will introduce new plant biotechnologies from PBL into maize and sweet sorghum, bring to field testing and ultimately develop new varieties suitable for commercial release in China.
Key regulator of plant root growth identified
New technology for enhancing root hair growth and nutrient uptake
In a paper published on-line this month in Nature Genetics, Keke et al demonstrate that a gene called RSL4 is the master regulator of root hair growth. Root hairs are vital for nutrient uptake from the soil and are critical to allow the roots of young seedlings penetrate the soil at germination.
Sarum Biosciences signs licence agreement with PBL for Clostridium difficile bacteriophage endolysin technology
22 January 2010: Sarum Biosciences Limited ("Sarum") and PBL, today announced the signing of an exclusive worldwide licence agreement which enables Sarum to develop and exploit therapeutic and diagnostic applications of a bacteriophage endolysin protein for the treatment and detection of Clostridium difficile, a serious healthcare concern both within the UK and the rest of the world.
|©2017 PBL Technology|